Arbutus Biopharma Corp. (ABUS)
4.24
-0.13
(-2.97%)
USD |
NASDAQ |
Mar 20, 16:00
4.25
+0.01
(+0.24%)
After-Hours: 20:00
Arbutus Biopharma Research and Development Expense (Quarterly) : 5.778M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Moderna, Inc. | 708.00M |
| Merck & Co., Inc. | 2.499B |
| Pfizer Inc. | 3.133B |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |